Bio-Path Holdings Inc (BPTH)

1.26 -0.23 (-15.44%) USD  |  NASDAQ  |  Dec 20, 16:00
1.18 -0.08 (-6.35%) After-Hours: 20:00
More

Bio-Path Holdings Enterprise Value: 4.865M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for BPTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Humacyte Inc 576.45M
NovaBay Pharmaceuticals Inc 1.870M
Palatin Technologies Inc 16.54M
iBio Inc 12.59M
Theriva Biologics Inc -13.07M

Enterprise Value Related Metrics

Net Income (Quarterly) -2.115M
Total Expenses (Quarterly) 2.634M
EPS Diluted (Quarterly) -0.70
Earnings Yield -875.4%
Normalized Earnings Yield -31766.54